The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
23andMe Holding Co. COM CL A 90138Q108 2,710 406,913 SH   SOLE   406,913 0 0
Aclaris Therapeutics, Inc. COM 00461U105 18,295 1,258,243 SH   SOLE   1,258,243 0 0
Adagio Therapeutics, Inc. COM 00534A102 12,669 1,745,060 SH   SOLE   1,745,060 0 0
Adicet Bio, Inc. COM 007002108 11,893 680,000 SH   SOLE   680,000 0 0
Compass Therapeutics, Inc. COM 20454B104 13,948 4,400,000 SH   SOLE   4,400,000 0 0
Cue Health Inc. COM 229790100 15,660 1,167,782 SH   SOLE   1,167,782 0 0
Cullinan Oncology, Inc. COM 230031106 17,637 1,143,006 SH   SOLE   1,143,006 0 0
Gemini Therapeutics, Inc. COM 36870G105 7,086 2,435,125 SH   SOLE   2,435,125 0 0
Hims & Hers Health, Inc. COM CL A 433000106 11,180 1,706,922 SH   SOLE   1,706,922 0 0
Kinnate Biopharma Inc. COM 49705R105 15,505 875,001 SH   SOLE   875,001 0 0
Pardes Biosciences Inc COM 69945Q105 153,886 9,400,515 SH   SOLE   9,400,515 0 0
Pharvaris N.V. COM N69605108 491 34,142 SH   SOLE   34,142 0 0
Quantum-Si Incorporated COM CL A 74765K105 18,432 2,342,061 SH   SOLE   2,342,061 0 0
Research Alliance Corp. II COM CL A 760873109 4,885 500,000 SH   SOLE   500,000 0 0
Somalogic, Inc. COM CL A 83444K105 62,000 5,326,472 SH   SOLE   5,326,472 0 0
TheseusPharmaceuticals, Inc. COM 88369M101 40,737 3,212,732 SH   SOLE   3,212,732 0 0